Treatment
68Ga-Pentixafor clinical trials
We’re tracking 10 recruiting studies that include 68Ga-Pentixafor, each written for real people, not researchers, below.
Recruiting studies
- NCT05188872Recruiting
PET scan for adrenal hormone condition before and after treatment
This trial uses a special PET scan to look at a hormone gland condition called primary aldosteronism, which can cause high blood pressure. It aims to see if the scan helps doctors plan treatment and check results.
Fuzhou, FujianAges 19–90 - NCT06238232Recruiting
Comparing a new PET scan to standard vein sampling for adrenal disease
This study compares a newer, less invasive PET/CT scan (using 68Ga-Pentixafor) to the standard adrenal vein sampling test to identify which adrenal gland is causing high blood pressure in people with primary aldosteronism. If you're considering surgery to remove a nodule on your adrenal gland, this trial may help determine the best approach.
Chongqing, Chongqing MunicipalityAges 18–70 - NCT06635993Recruiting
Testing a PET scan for aldosterone and cortisol condition
This trial tests whether a special PET/CT scan (68Ga-Pentixafor) can accurately identify the subtype of primary aldosteronism in people who also have excess cortisol. It may help determine if surgery is the right treatment for you.
Chongqing, Chongqing MunicipalityAges Any age - NCT06833437Recruiting
New PET scan versus blood test for adrenal condition
This trial tests a special PET scan (68Ga-Pentixafor) to see if it can replace a more invasive blood test (AVS) for finding which adrenal gland is causing high blood pressure and high cortisol levels. It may help patients avoid a complicated procedure.
Chongqing, Chongqing MunicipalityAges 18–70 - NCT06834412Recruiting
New PET scan for blood cancer staging
This study tests a new type of PET scan called 68Ga-Pentixafor to see how well it finds and stages blood cancers (like non-Hodgkin lymphoma and myeloma). It will compare this new scan to the standard FDG-PET scan. If you join, you may get more accurate information about your cancer.
Xi'an, ShaanxiAges 18–75 - NCT07350707RecruitingPhase 1/Phase 2
PET scan for Cushing's syndrome using two tracers
This trial tests if a special PET scan using two different tracers (68Ga-Pentixafor and 68Ga-DOTATATE) can help diagnose Cushing's syndrome and find its cause. It may help doctors better understand your condition and guide treatment.
Beijing, Beijing MunicipalityAges 10–80 - NCT07605156Recruiting
New imaging scan for rare adrenal hormone tumors
This study tests a special imaging scan (PET/CT) to help doctors identify adrenal tumors that produce too much of two hormones: aldosterone and cortisol. If you have both hormone imbalances confirmed by blood tests and are planning surgery to remove your adrenal gland, this scan may help your doctors see exactly where the tumor is.
BeijingAges 18–80 - NCT04504526RecruitingEarly Phase 1
New imaging for diagnosing lymphoma
This study tests a new imaging method called CXCR4 PET/CT that may help doctors better see and understand lymphomas (a type of blood cancer). It is for people who are newly diagnosed or suspected of having lymphoma and have already had a standard PET/CT.
Fuzhou, FujianAges 18–80 - NCT05255926Recruiting
CXCR4 scan test using PET/CT for blood cancers
This trial looks at an imaging scan called CXCR4-targeted PET/CT to help doctors see certain blood cancers. You may be helped by getting clearer information about where cancer is in your body, and the results may guide future care.
Wuhan, HubeiAges 18–90 - NCT07027254Recruiting
Can a special PET scan improve surgery for primary aldosteronism?
This study uses a new type of PET scan (called Gallium-68 Pentixafor PET-CT) to help doctors better identify the source of a hormone problem causing high blood pressure. The goal is to see if this scan leads to better surgical outcomes compared to standard methods.
Seoul, Gangnam-guAges 19 years+
What 68Ga-Pentixafor is being studied for
Conditions with recruiting 68Ga-Pentixafor studies.
Common questions
- Are there clinical trials studying 68Ga-Pentixafor?
- Yes. Clin2 currently lists 10 recruiting studies that include 68Ga-Pentixafor, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a 68Ga-Pentixafor trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is 68Ga-Pentixafor an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether 68Ga-Pentixafor or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.